New treatments in Alzheimer's disease

Pickrell, William O. and Robertson, Neil P. 2018. New treatments in Alzheimer's disease. Journal of Neurology 265 (9) , pp. 2162-2163. 10.1007/s00415-018-9018-1

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (535kB) | Preview

Abstract

Alzheimer’s disease is the most common cause of dementia, affecting around 50 million people worldwide. Its prevalence is increasing mainly as a result of an ageing population with considerable associated increases in health and social care costs. As a result, government agencies worldwide have turned funding streams towards unravelling biological mechanisms and developing therapeutic opportunities for the dementias in general. Consequently, a number of novel potential treatments have been developed, although, to date, they have not been shown to significantly alter disease course. In this month’s journal club we look at three large clinical trials of new treatments in Alzheimer’s disease.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	Springer
ISSN:	0340-5354
Date of First Compliant Deposit:	18 September 2018
Date of Acceptance:	31 July 2018
Last Modified:	25 Feb 2019 11:40
URI:	https://orca.cardiff.ac.uk/id/eprint/115036

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item